Section

Stocks

UnitedHealth beat Wall Street’s second-quarter estimates and raised its 2026 earnings target while warning medical costs remain hi...

Read

The new Fed chair avoided major hearing stumbles, but his inflation framework is already under pressure from lawmakers, markets an...

Read

Lilly is buying the psychedelic drug developer to add late-stage depression treatments based on DMT and MDMA to its pipeline.

Read

Tehran warned it would retaliate if the U.S. targets Iranian infrastructure, raising pressure around a key oil-shipping route.

Read

The Bengaluru startup raised $300 million at a $1.5 billion valuation, adding momentum to India’s still-developing AI sector.

Read

James Patten argues he should avoid prison after pleading guilty in a stock manipulation scheme tied to a tiny New Jersey deli.

Read

Mykhailo Fedorov’s exit adds political uncertainty in Kyiv as Ukraine changes top posts during its war with Russia.

Read

The Fed’s Beige Book showed World Cup tourism helped host cities, while higher costs and weaker local spending limited the wider p...

Read

Prediction-market traders are pricing in a sharp chance that the U.S. gas average tops $4 as oil rises and U.S.-Iran tensions inte...

Read

United topped second-quarter forecasts, but higher jet fuel prices tied to U.S.-Iran conflict are pressuring margins and its near-...

Read

J&J topped second-quarter estimates and lifted its 2026 outlook, but shares fell as investors focused on softness in its MedTech c...

Read

New York’s one-year limit on certain power-hungry data centers puts AI infrastructure, utility bills and state politics in the sam...

Read